Why Just offer ABHR's?

It is of key interest that decision makers look to what is an old recommendation from bodies such as CDC and WHO on the use of Alcohol Based Hand Rubs (ABHR’s), when in so many other aspects they are looking for the latest product and advice.

The recommendations, and I stress recommendation not legal requirement was made some 13 years ago and in that time frame issues have arisen with the use of ABHR’s and the development of non alcohol based hand rubs which have gone through rigorous efficacy testing.

The focus of any Healthcare Facility should be compliance with the hand hygiene protocols laid out for Healthcare Workers (HCW’s) it is totally irrelevant what product is used and recommended by the CDC and WHO, if HCW’s do not comply with the use of ABHR’s for which there are a number of reasons.

A forward looking Healthcare Facility will look to meet the need for increasing their compliance rate by at least a minimum offering a choice of hand rubs, not just ABHR’s.

Questions that need to be asked by a key person within the facility are:

Do we know what is the components and strength of the ABHR we use, as these are key to the efficacy of the product?

If the facility uses a hand gel, do our HCW’s wash their hands after 8-10 uses as recommended by the authorities and manufacturers? This is due to efficacy decreasing with the build up of the gel component on the hands.

So are there enough hand washing facilities?

Do the HCW’s keep their hands wet for 30 seconds using ABHR’s and therefore re-apply if they are not, as recommended by the authorities and manufacturers.

Do the HCW’s conduct a full Ayliff technique or does the ABHR dry too quickly?

Are HCW’s avoiding the use of ABHR’s, this can be for a number of reasons, so are the required compliance levels being met or improving?

If the answer to any of the questions is no then the facility will not be meeting required compliance levels and therefore failing in it’s duty of care.

Is the ABHR being stored correctly, meeting fire regulations?

How much is known about the developing resistance to ABHR’s?

There are viable alternatives in non ABHR’s, giving choice to the end user and improving hand hygiene compliance rates.

As to why the CDC and WHO have not reviewed in any depth, only they can answer.

Distributor Partner Agreement for Thailand

Ebiox is very pleased to announce that they have completed an agreement with the Safe Siam Business Group Co Ltd.

We are delighted that an agreement for distribution of the Ebiox Product Portfolio has been reached with the Safe Siam Business Group Co Ltd covering Thailand. They are well positioned and experienced in the field of decontamination and extends our reach into what is an extremely important geographical region.

Further Fraudulent Evidence of ex Ebiox Limited distributor in China

We have received more evidence of our ex distributor in China, Dalian EBOS Technology Co.Ltd in Dalian City has issued fraudulent documents stating that the EBOS Group Limited has authorised that they have the distributor rights in China.
There is no such authorisation and there are no such products made in the UK under the EBOS brand. They have change the logo and company name from Ebiox. They are not at the registered office they state.
Anyone purchasing product from them are buying product made in China and has no testing related to that of the Ebiox Limited product.
We would advise anyone purchasing product from Dalian EBOS Technology to stop immediately.

Ebiox and MERS

With the increase in concern from the countries involved and the WHO with reference to the growing number of reported MERS cases and deaths, Ebiox finds itself well positioned to help in offering a package of decontamination products which will reduce the potential impact of such an outbreak.

Linked with our strong Distributor Partners in the Middle East, Ebiox can offer a range of hand hygiene, environmental decontamination products and healthcare workers clothing which could help reduce the impact of MERS. For further information please go to our website www.ebiox.co.uk you will find the contact details of our partners in the Middle East or information on how to contact us directly.

Ebiox agrees to expand the geographical territory of their Distributor Partner based in Turkey.

We are very pleased to announce that our Turkish Distributor Partner has recognised the potential of the Ebiox Product Portfolio and that an agreement was reached today for them to expand their geographical territory to now include Azerbaijan. We wish them every success.

Ebiox has signed a Partner Distribution Agreement for the Zhejiang Province.

Ebiox is pleased to announce that they have signed an agreement with Kanbeier Medical who are based in Hangzhou, Zheijang Province with a focus on rebuilding the brand and sales into the Chinese Healthcare Market.

Distribution Agreement with Dalian EBOS (China) Has Been Terminated

Due to actions taken by Dalian EBOS the distributor for Ebiox products in China we have no other course but to terminate the distribution agreement which we held with them.

It should be noted that no products or communications under the name EBOS or Ebos Medical Co Ltd have any connection or authorisation from Ebiox Limited.